This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by May, A. K. Articles by Pruett, T. L. Search for Related Content PubMed PubMed Citation Articles by May, A. K. Articles by Pruett, T. L.

 Previous Article  |  Next Article 

Infect. Immun., Jun 1996, 2167-2171, Vol 64, No. 6
Copyright © 1996, American Society for Microbiology

In vivo cytokine response to Escherichia coli alpha-hemolysin determined with genetically engineered hemolytic and nonhemolytic E. coli variants

AK May, RG Sawyer, T Gleason, A Whitworth and TL Pruett
Department of Surgery, Surgical Infectious Disease Laboratory, University of Virginia, Charlottesville 22908, USA.

Alpha-hemolysin is an Escherichia coli exotoxin that enhances bacterial virulence, has profound effects on leukocytes in vitro, and induces the release of interleukin-1 (IL-1) but not tumor necrosis factor (TNF) from human monocytes in vitro. The purpose of this study was to examine alpha-hemolysin's influence on virulence and TNF and IL-1 production in vivo. Two genetically engineered, isogeneic strains of E. coli were used; one variant produces alpha-hemolysin, and the other does not. Male BALB/c mice were injected with either of the two variants and serum TNF and IL-1 were assayed. These results were compared with those obtained from the injection of either of two serotypes of lipopolysaccharide (LPS). The nonhemolytic E. coli strain produced no mortality and no significant elevation of serum TNF or IL-1 levels. In contrast, equal inocula of the hemolytic E. coli strain produced significant mortality and elevation of serum IL-1 levels. No significant elevation of TNF levels was detected in this group despite high-level mortality. A pattern of induction of mortality and elevation of serum IL-1 levels without elevation of serum TNF levels is distinct from the pattern typical of LPS. In these experiments, both serotypes of LPS caused elevations of TNF and IL-1 levels whether or not mortality was induced. Thus, alpha-hemolysin produces a cytokine response in vivo that is similar to that previously demonstrated in vitro by Bhakdi et al. (S. Bhakdi, M. Muhly, S. Korom, and G. Schmidt, J. Clin. Invest. 85:1746-1753, 1990) and appears to induce mortality independently of serum TNF.

This article has been cited by other articles:

• Noskov, S. Yu., Im, W., Roux, B. (2004). Ion Permeation through the {alpha}-Hemolysin Channel: Theoretical Studies Based on Brownian Dynamics and Poisson-Nernst-Plank Electrodiffusion Theory. Biophys. J 87: 2299-2309 [Abstract] [Full Text]  
• Ghannoum, M. A. (2000). Potential Role of Phospholipases in Virulence and Fungal Pathogenesis. Clin. Microbiol. Rev. 13: 122-143 [Abstract] [Full Text]  
• May, A. K., Gleason, T. G., Sawyer, R. G., Pruett, T. L. (2000). Contribution of Escherichia coli Alpha-Hemolysin to Bacterial Virulence and to Intraperitoneal Alterations in Peritonitis. Infect. Immun. 68: 176-183 [Abstract] [Full Text]  
• Gleason, T. G., Houlgrave, C. W., May, A. K., Crabtree, T. D., Sawyer, R. G., Denham, W., Norman, J. G., Pruett, T. L. (1998). Hemolytically Active (Acylated) Alpha-Hemolysin Elicits Interleukin-1beta (IL-1beta ) but Augments the Lethality of Escherichia coli by an IL-1- and Tumor Necrosis Factor-Independent Mechanism. Infect. Immun. 66: 4215-4221 [Abstract] [Full Text]  
• Stanley, P., Koronakis, V., Hughes, C. (1998). Acylation of Escherichia coli Hemolysin: A Unique Protein Lipidation Mechanism Underlying Toxin Function. Microbiol. Mol. Biol. Rev. 62: 309-333 [Abstract] [Full Text]